TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Biorega AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
233
|
409
|
29 |
| Financial expenses |
28
|
0
|
1 |
| Earnings before taxes |
1,343
|
4,453
|
-9 |
| EBITDA |
-30
|
-141
|
-9 |
| Total assets |
4,407
|
5,629
|
1,318 |
| Current assets |
4,020
|
5,629
|
183 |
| Current liabilities |
78
|
448
|
625 |
| Equity capital |
4,308
|
5,168
|
685 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
97.8%
|
91.8%
|
52.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
576.4%
|
1088.8%
|
-31.0% |
| Return on assets (ROA) |
31.1%
|
79.1%
|
-0.6% |
| Current ratio |
5153.8%
|
1256.5%
|
29.3% |
| Return on equity (ROE) |
31.2%
|
86.2%
|
-1.3% |
| Change turnover |
-184
|
378
|
29 |
| Change turnover % |
-44%
|
1203% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.